An analysis of NIV use among patients with spinal muscular atrophy and amyotrophic lateral sclerosis included in the RARAS project between 2018 and 2024
Abstract
Background: Neuromuscular diseases, such as Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy, encompass a diverse group of conditions that affect the motor unit, resulting in muscle weakness, atrophy, and respiratory compromise. These diseases often present a progressive course, leading to significant challenges in mobility and quality of life for patients. The challenges faced include not only muscle weakness and atrophy but also respiratory complications that can impair an individual’s autonomy. Non-invasive ventilation emerges as a crucial intervention, improving respiratory function and consequently enhancing the patient’s quality of life. However, understanding of its long-term use in patients with these conditions is still limited. This study aims to evaluate the use of Non-invasive ventilation (NIV) in patients with Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy, identifying criteria for indication, barriers to proper use, and its effects on health over a follow-up period Objective: This study aims to assess the use of Non-invasive ventilation in patients with Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy who participated in the RARAS project - National Network for Rare Diseases - from 2018 to 2024, focusing on its indication and use, barriers, disease duration, and hospitalization quantification Methods: A longitudinal, prospective study involving 38 individuals, including children and adults diagnosed with Amyotrophic Lateral Sclerosis or Spinal Muscular Atrophy, was conducted in a reference outpatient clinic with indications for non-invasive ventilation. The study will analyze the criteria for NIV indication, the time between indication and use, difficulties in acquiring and using the NIV device, the number of hospitalizations before and after NIV implementation, and the time from the onset of the disease to the use of the device. Data collection was conducted through patient history and record analysis. The data were statistically analyzed. Results: The use of non-invasive ventilation is associated with a reduction in the number of hospitalizations due to respiratory complaints. Furthermore, more than half of the participants reported difficulties on using the device, with poor adaptation to the Non-invasive ventilation interface being the main complaint. An average of four and a half months was observed between the indication and effective use of the device among patients with record Conclusion: The study highlights the importance of Non-invasive ventilation as a vital therapeutic intervention for patients with neuromuscular diseases. Proper indication and appropriate use of Non-invasive ventilation, along with special attention to the difficulties faced by patients, are crucial for optimizing quality of life and reducing the frequency of hospitalizations